Main variables;Main activity, secondary one or a tool necessary for production;Total
Companies that carry out R&D in Biotechnology;Total;1.079
Companies that carry out R&D in Biotechnology;Main;519
Companies that carry out R&D in Biotechnology;Secondary dwellings;179
Companies that carry out R&D in Biotechnology;Tool;381
%Companies according to biotechnology used: Genetic code;Total;35
%Companies according to biotechnology used: Genetic code;Main;46
%Companies according to biotechnology used: Genetic code;Secondary dwellings;29
%Companies according to biotechnology used: Genetic code;Tool;23
%Companies according to biotechnology used: Functional units;Total;44
%Companies according to biotechnology used: Functional units;Main;55
%Companies according to biotechnology used: Functional units;Secondary dwellings;40
%Companies according to biotechnology used: Functional units;Tool;32
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Total;26
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Main;34
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Secondary dwellings;24
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Tool;17
%Companies according to biotechnology used: Bioprocesses;Total;49
%Companies according to biotechnology used: Bioprocesses;Main;42
%Companies according to biotechnology used: Bioprocesses;Secondary dwellings;46
%Companies according to biotechnology used: Bioprocesses;Tool;61
%Companies according to biotechnology used: Sub-cellular organisms;Total;8
%Companies according to biotechnology used: Sub-cellular organisms;Main;12
%Companies according to biotechnology used: Sub-cellular organisms;Secondary dwellings;6
%Companies according to biotechnology used: Sub-cellular organisms;Tool;5
%Companies according to biotechnology used: Bio-computing;Total;23
%Companies according to biotechnology used: Bio-computing;Main;35
%Companies according to biotechnology used: Bio-computing;Secondary dwellings;15
%Companies according to biotechnology used: Bio-computing;Tool;10
%Companies according to biotechnology used: Nanobiotechnology;Total;15
%Companies according to biotechnology used: Nanobiotechnology;Main;23
%Companies according to biotechnology used: Nanobiotechnology;Secondary dwellings;13
%Companies according to biotechnology used: Nanobiotechnology;Tool;4
%Companies according to biotechnology used: Other;Total;12
%Companies according to biotechnology used: Other;Main;12
%Companies according to biotechnology used: Other;Secondary dwellings;18
%Companies according to biotechnology used: Other;Tool;10
%Company by field(s) of ultimate application of biotechnology use: Human Health;Total;48
%Company by field(s) of ultimate application of biotechnology use: Human Health;Main;68
%Company by field(s) of ultimate application of biotechnology use: Human Health;Secondary dwellings;43
%Company by field(s) of ultimate application of biotechnology use: Human Health;Tool;22
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Total;21
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Main;25
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Secondary dwellings;15
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Tool;17
%Company by field(s) of ultimate application of biotechnology use: Food products;Total;33
%Company by field(s) of ultimate application of biotechnology use: Food products;Main;25
%Company by field(s) of ultimate application of biotechnology use: Food products;Secondary dwellings;30
%Company by field(s) of ultimate application of biotechnology use: Food products;Tool;46
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Total;22
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Main;22
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Secondary dwellings;21
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Tool;22
%Company by field(s) of ultimate application of biotechnology use: Environment;Total;17
%Company by field(s) of ultimate application of biotechnology use: Environment;Main;15
%Company by field(s) of ultimate application of biotechnology use: Environment;Secondary dwellings;25
%Company by field(s) of ultimate application of biotechnology use: Environment;Tool;17
%Company by field(s) of ultimate application of biotechnology use: Industry;Total;15
%Company by field(s) of ultimate application of biotechnology use: Industry;Main;16
%Company by field(s) of ultimate application of biotechnology use: Industry;Secondary dwellings;20
%Company by field(s) of ultimate application of biotechnology use: Industry;Tool;10
Personnel in R&D in biotechnology (no. of persons);Total;9.795
Personnel in R&D in biotechnology (no. of persons);Main;5.614
Personnel in R&D in biotechnology (no. of persons);Secondary dwellings;1.560
Personnel in R&D in biotechnology (no. of persons);Tool;2.621
Personnel in R&D in biotechnology (no. of persons): Researchers;Total;5.573
Personnel in R&D in biotechnology (no. of persons): Researchers;Main;3.578
Personnel in R&D in biotechnology (no. of persons): Researchers;Secondary dwellings;874
Personnel in R&D in biotechnology (no. of persons): Researchers;Tool;1.122
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Total;4.222
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Main;2.036
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Secondary dwellings;686
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Tool;1.500
Personnel in R&D in biotechnology (no. of persons): women;Total;5.298
Personnel in R&D in biotechnology (no. of persons): women;Main;3.242
Personnel in R&D in biotechnology (no. of persons): women;Secondary dwellings;813
Personnel in R&D in biotechnology (no. of persons): women;Tool;1.243
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Total;2.925
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Main;1.944
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Secondary dwellings;462
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Tool;520
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Total;2.373
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Main;1.298
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Secondary dwellings;352
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Tool;724
Personnel in R&D in biotechnology (FTE);Total;6.828,6
Personnel in R&D in biotechnology (FTE);Main;4.507,9
Personnel in R&D in biotechnology (FTE);Secondary dwellings;873,3
Personnel in R&D in biotechnology (FTE);Tool;1.447,5
Personnel in R&D in biotechnology (FTE): Researchers;Total;4.106,5
Personnel in R&D in biotechnology (FTE): Researchers;Main;2.926,2
Personnel in R&D in biotechnology (FTE): Researchers;Secondary dwellings;542,5
Personnel in R&D in biotechnology (FTE): Researchers;Tool;637,8
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Total;2.722,1
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Main;1.581,7
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Secondary dwellings;330,8
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Tool;809,6
Personnel in R&D in biotechnology (FTE): women;Total;3.811,7
Personnel in R&D in biotechnology (FTE): women;Main;2.613,9
Personnel in R&D in biotechnology (FTE): women;Secondary dwellings;467,5
Personnel in R&D in biotechnology (FTE): women;Tool;730,3
Personnel in R&D in biotechnology (FTE): (women) Researchers;Total;2.190,7
Personnel in R&D in biotechnology (FTE): (women) Researchers;Main;1.587,2
Personnel in R&D in biotechnology (FTE): (women) Researchers;Secondary dwellings;290,9
Personnel in R&D in biotechnology (FTE): (women) Researchers;Tool;312,7
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Total;1.621
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Main;1.026,8
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Secondary dwellings;176,7
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Tool;417,6
Internal expenditure on R&D (thousands of euros);Total;533.826
Internal expenditure on R&D (thousands of euros);Main;364.396
Internal expenditure on R&D (thousands of euros);Secondary dwellings;71.517
Internal expenditure on R&D (thousands of euros);Tool;97.913
1) By nature of the expense: Current expenses;Total;492.955
1) By nature of the expense: Current expenses;Main;336.315
1) By nature of the expense: Current expenses;Secondary dwellings;63.751
1) By nature of the expense: Current expenses;Tool;92.889
1.1) Remuneration to researchers;Total;203.439
1.1) Remuneration to researchers;Main;146.489
1.1) Remuneration to researchers;Secondary dwellings;27.774
1.1) Remuneration to researchers;Tool;29.176
1.2) Remuneration to technicians and assistants;Total;96.850
1.2) Remuneration to technicians and assistants;Main;59.163
1.2) Remuneration to technicians and assistants;Secondary dwellings;11.408
1.2) Remuneration to technicians and assistants;Tool;26.279
1.3) Other current expenses;Total;192.666
1.3) Other current expenses;Main;130.663
1.3) Other current expenses;Secondary dwellings;24.568
1.3) Other current expenses;Tool;37.434
2) By nature of the expense: Capital expenses;Total;40.870
2) By nature of the expense: Capital expenses;Main;28.081
2) By nature of the expense: Capital expenses;Secondary dwellings;7.766
2) By nature of the expense: Capital expenses;Tool;5.024
2.1) Land and buildings;Total;7.521
2.1) Land and buildings;Main;3.628
2.1) Land and buildings;Secondary dwellings;3.306
2.1) Land and buildings;Tool;587
2.2) Equipment and instruments;Total;32.078
2.2) Equipment and instruments;Main;23.504
2.2) Equipment and instruments;Secondary dwellings;4.431
2.2) Equipment and instruments;Tool;4.144
2.3) Acquisition of specific R+D software;Total;1.270
2.3) Acquisition of specific R+D software;Main;949
2.3) Acquisition of specific R+D software;Secondary dwellings;28
2.3) Acquisition of specific R+D software;Tool;293
1) By origin of the funds: National funds;Total;432.869
1) By origin of the funds: National funds;Main;285.656
1) By origin of the funds: National funds;Secondary dwellings;66.748
1) By origin of the funds: National funds;Tool;80.466
1.1) Own funds;Total;319.046
1.1) Own funds;Main;209.128
1.1) Own funds;Secondary dwellings;49.733
1.1) Own funds;Tool;60.186
1.2) From companies;Total;39.253
1.2) From companies;Main;26.512
1.2) From companies;Secondary dwellings;5.269
1.2) From companies;Tool;7.473
1.3) Public Administration funds;Total;70.063
1.3) Public Administration funds;Main;47.559
1.3) Public Administration funds;Secondary dwellings;11.542
1.3) Public Administration funds;Tool;10.962
1.4) From Universities;Total;156
1.4) From Universities;Main;131
1.4) From Universities;Secondary dwellings;10
1.4) From Universities;Tool;14
1.5) From non profit private institutions;Total;4.351
1.5) From non profit private institutions;Main;2.326
1.5) From non profit private institutions;Secondary dwellings;194
1.5) From non profit private institutions;Tool;1.831
1) By origin of the funds: Foreign funds;Total;100.956
1) By origin of the funds: Foreign funds;Main;78.740
1) By origin of the funds: Foreign funds;Secondary dwellings;4.769
1) By origin of the funds: Foreign funds;Tool;17.447
2.1) From EU programmes;Total;20.070
2.1) From EU programmes;Main;15.152
2.1) From EU programmes;Secondary dwellings;3.718
2.1) From EU programmes;Tool;1.200
2.2) Other foreign funds;Total;80.886
2.2) Other foreign funds;Main;63.588
2.2) Other foreign funds;Secondary dwellings;1.051
2.2) Other foreign funds;Tool;16.247
Purchase of R&D services in biotechnology (thousands of euros);Total;138.625
Purchase of R&D services in biotechnology (thousands of euros);Main;109.756
Purchase of R&D services in biotechnology (thousands of euros);Secondary dwellings;20.480
Purchase of R&D services in biotechnology (thousands of euros);Tool;8.390
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Total;101.114
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Main;75.199
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Secondary dwellings;17.964
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Tool;7.950
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Total;37.512
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Main;34.557
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Secondary dwellings;2.515
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Tool;440
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Total;46
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Main;57
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Secondary dwellings;43
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Tool;33
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Total;13
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Main;12
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Secondary dwellings;15
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Tool;14
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Total;12
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Main;14
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Secondary dwellings;15
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Tool;8
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Total;14
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Main;14
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Secondary dwellings;19
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Tool;12
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Total;19
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Main;21
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Secondary dwellings;23
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Tool;14
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Total;19
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Main;23
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Secondary dwellings;22
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Tool;13
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Total;18
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Main;19
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Secondary dwellings;16
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Tool;16
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Total;37
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Main;41
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Secondary dwellings;42
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Tool;30
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Total;49
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Main;53
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Secondary dwellings;57
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Tool;41
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Total;19
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Main;21
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Secondary dwellings;20
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Tool;16
% Companies that have requested biotechnology patents;Total;15
% Companies that have requested biotechnology patents;Main;23
% Companies that have requested biotechnology patents;Secondary dwellings;13
% Companies that have requested biotechnology patents;Tool;6
Number of patents requested;Total;466
Number of patents requested;Main;349
Number of patents requested;Secondary dwellings;74
Number of patents requested;Tool;42
% Companies with income of an international origin related to biotechnological activities;Total;24,9
% Companies with income of an international origin related to biotechnological activities;Main;33
% Companies with income of an international origin related to biotechnological activities;Secondary dwellings;14,5
% Companies with income of an international origin related to biotechnological activities;Tool;18,8
% Turnover representing income of an international origin related to biotechnological activities;Total;0,9
% Turnover representing income of an international origin related to biotechnological activities;Main;11,2
% Turnover representing income of an international origin related to biotechnological activities;Secondary dwellings;0
% Turnover representing income of an international origin related to biotechnological activities;Tool;0,3
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Total;71,3
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Main;76,7
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Secondary dwellings;54,2
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Tool;32
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Total;28,7
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Main;23,3
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Secondary dwellings;45,8
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Tool;68
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Total;92,2
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Main;92,9
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Secondary dwellings;56,5
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Tool;92,4
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Total;2,4
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Main;2,2
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Secondary dwellings;23,8
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Tool;0,6
% Income of an international origin related with activities according to the classification: Operating source abroad;Total;1,3
% Income of an international origin related with activities according to the classification: Operating source abroad;Main;0,9
% Income of an international origin related with activities according to the classification: Operating source abroad;Secondary dwellings;19,7
% Income of an international origin related with activities according to the classification: Operating source abroad;Tool;0,7
% Income of an international origin related with activities according to the classification: Other;Total;4,2
% Income of an international origin related with activities according to the classification: Other;Main;4
% Income of an international origin related with activities according to the classification: Other;Secondary dwellings;.
% Income of an international origin related with activities according to the classification: Other;Tool;6,3